Answers are grounded in this paper and cite their sources.
Photodynamic therapy (PDT) involves the selective sensitization of tissues to light. A major advance in the field occurred when Thomas Dougherty at the Roswell Park Cancer Institute initiated a series of clinical studies that eventually led to FDA approval of the procedure. This report contains a summary of Dougherty's contributions and an assessment of where this has led, along with a summary of implications for future drug development.
No takes yet. Share an insight, caveat, or question.
David Kessel (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: